Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Short Interest Update

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) saw a large drop in short interest in the month of March. As of March 13th, there was short interest totaling 3,182 shares, a drop of 57.0% from the February 26th total of 7,403 shares. Based on an average trading volume of 28,111 shares, the days-to-cover ratio is currently 0.1 days.

Coeptis Therapeutics Trading Down 0.7%

Shares of COEPW stock opened at $0.01 on Thursday. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.02. Coeptis Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.05.

About Coeptis Therapeutics

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.